Price, T.J.Peeters, M.Ruff, P.Murugappan, S.Sidhu, R.2015-08-182015-08-182014The Lancet Oncology, 2014; 15(8):e303-e3031470-20451474-5488http://hdl.handle.net/2440/93646CorrespondenceenCopyright status unknownHumansColorectal NeoplasmsAntineoplastic AgentsAntibodies, MonoclonalFemaleMaleAntibodies, Monoclonal, HumanizedAuthors' replyASPECCT: panitumumab versus cetuximab for colorectal cancer – authors' replyJournal article003002128210.1016/S1470-2045(14)70291-80003397330000082-s2.0-84903459687170576Price, T.J. [0000-0002-3922-2693]Peeters, M. [0000-0003-4969-2303]